Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1225 of 6351
-
New hope for kids with stubborn kawasaki disease: drug targets fever and heart risks
Disease control CompletedThe purpose of this study is to evaluate the efficacy and safety of TA-650 in comparison with a control drug Polyethylene Glycol-treated Human Immunoglobulin (VGIH) in patients with Kawasaki disease refractory to initial therapy with Intravenous Immunoglobulin (IVIG). The pharmac…
Phase 3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Meningitis b vaccine booster shows promise in kids
Vaccine CompletedThe main objective of the study is to estimate the proportion of children, born between the 06/04/2004 and the 17/004/2008, living around Neufchatel en Bray, vaccinated by MenBVac, with a serum bactericidal activity against B:14,P1-7,16 clone related to a protection (\>= 4), befo…
Phase 3 • Sponsor: University Hospital, Rouen • Aim: Vaccine
Last updated Jun 27, 2026 13:07 UTC
-
New cocktail aims to knock out leukemia for good
Disease control CompletedThe main purpose of this study is to see if ofatumumab with methylprednisolone followed by additional treatment with ofatumumab and lenalidomide can help people with Chronic Lymphocytic Leukemia (CLL) get rid of their CLL for a long period of time. Researchers also want to find o…
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could a daily pill boost blood counts in aplastic anemia?
Disease control CompletedBackground: * Moderate aplastic anemia is a blood disease which may require frequent blood and platelet transfusions. Sometimes patients with this disease can be treated with immunosuppressive drugs. Not all patients respond and not all patients are suitable for this treatment. …
Phase 2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Gene tests could unlock personalized cancer therapies for thousands
Knowledge-focused Recruiting nowThis study performs standardized testing of tumor tissue samples to learn which genes are mutated (have changed) in order to provide personalized cancer therapy options to cancer patients at MD Anderson. This may help doctors use testing information on tumors to identify clinical…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Norway launches massive colorectal cancer screening showdown: which test saves more lives?
Prevention OngoingThe Norwegian government has funded a pilot study of a national colorectal cancer screening programme. This implies initiation of a screening pilot in the catchment area for two hospitals in Norway. The target population is average risk men and women at age 50-74 years. The progr…
Sponsor: Norwegian Institute of Public Health • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
Diet study hopes to boost survival in colorectal cancer patients
Disease control OngoingThe current study is designed to gain a better understanding of the role of a healthy diet aimed at dampening inflammation and oxidative stress on long-term disease outcomes and survival in colorectal cancer patients. Since previous research on the role of diet for colorectal can…
Sponsor: University of Oslo • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a turmeric compound shield Smokers' blood vessels?
Disease control CompletedThe aim of this study is to determine if an oral loading-dose of curcumin can improve vascular endothelium reactivity in patients with moderate cardiovascular risk
Phase 1/2 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New drug combo shows promise for returning bone marrow cancer
Disease control CompletedThis phase II trial studies how well ixazomib citrate works in treating patients with multiple myeloma that has returned after a period of improvement (relapsed) but is not resistant to bortezomib (refractory). Ixazomib citrate may stop the growth of cancer cells by blocking some…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Tears may hold key to spotting dangerous prostate cancer
Diagnosis OngoingThe purpose of this research study is to compare profiles in the blood and tears of patients with and without prostate cancer with the goal of developing a method of separating men with aggressive and non-aggressive disease.
Sponsor: University of Arkansas • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC
-
New drug combo aims to tame blood cancer without chemo
Disease control OngoingThe goal of this clinical research study is to learn if the combination of lenalidomide and rituximab can help to control CLL. The safety of this drug combination will also be studied. Lenalidomide is designed to change the body's immune system. It may also interfere with the de…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New pill shows promise for schizophrenia psychosis
Symptom relief CompletedThe purpose of this study is to evaluate whether ITI-007 is effective in reducing symptoms associated with schizophrenia in patients who are having an acute worsening of their psychosis. Patients will be randomly assigned to receive one of two doses of ITI-007, placebo, or a posi…
Phase 2 • Sponsor: Intra-Cellular Therapies, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Can tracking childhood cancer survivors reveal hidden late effects?
Knowledge-focused Recruiting nowThe FCCSS is a multicentric national large-scale collaborative population-based study of children treated for a solid tumor before 2000 in France and before the age of 19 years. The study is concerned by improving knowledge about the long-term effects caused by cancer and its tr…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC
-
New hope for advanced colon cancer: which drug combo works best?
Disease control Recruiting nowThe primary purpose of this study is to determine the non-inferiority of overall survival FOLFIRI with or without Bevacizumab compared with Irinotecan (CPT-11) with or without Bevacizumab as Second-line therapy in Patient with Metastatic Colorectal Cancer.
Phase 3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Massive study tests if daily pills can ward off diabetes
Prevention CompletedThe VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) is an ongoing randomized clinical trial in 25,875 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor® fish oil, 1 gram) reduces the risk of developi…
Phase 3 • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
Last hope? new combo targets tough hepatitis c cases
Disease control CompletedThis study will evaluate the efficacy and safety of MP-424 with Peginterferon Alfa-2b and Ribavirin (RBV) in patients with genotype 2 hepatitis C, who did not respond to previous treatment.
Phase 3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Cord blood transplants made more accessible for thousands with blood cancers
Disease control Recruiting nowThis study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.
Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Surgery vs. meds: which works better for diabetes in obese patients?
Disease control CompletedThe objectives are to compare the results of the Gastric By-Pass (GBP) to that of optimized medical therapy in patients with obesity and poorly controlled type 2 diabetes in terms of mortality, weight loss, glycemic control, quality of life, cost, cost-effectiveness and cost util…
Phase 4 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for rare sarcoma: two drugs face off in clinical trial
Disease control CompletedBackground: * Alveolar soft part sarcoma (ASPS) is a rare, highly vascular tumor accounting for less than 1% of soft tissue sarcomas. There is no effective systemic treatment for patients with metastatic ASPS. Little is known with regards to relevant molecular markers as potenti…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Estrogen cream may cut surgery complications in boys with birth defect
Disease control CompletedHypospadias is a congenital abnormality of the penis that is caused by incomplete development of the anterior urethra. This pathology is one of the most common genital anomalies in paediatric urology .The incidence is reported to be 1 out of 250 live male births and is increasing…
Phase 3 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 26, 2026 13:53 UTC